New approaches are needed to address the risk factors for heart attack, stroke, and other major cardiovascular events. RNAi technology, because of the way it works, has the potential to disrupt the ...

The research seeks to contain agricultural pests by targeting rootworm genes with RNAi technology. According to UNL, western corn rootworm annually causes up to $2 billion in yield loss and ...

But with new technology based on branched silencing RNA licensed from the University of Massachusetts Medical School, Atalanta says it could change this. Co-founded by Craig Mello, who won the ...

Alnylam’s RNAi technology could potentially mimic the naturally occurring loss of function genetic variation in HSD17B13 seen in people who are protected from NASH disease progression.

For example, Invitrogen has the Stealth RNAi technology. According to the company's literature, Stealth siRNAs are stable for 72 hours in serum and do not trigger the interferon response in cells.

Targovax ASA ( ($GB:0RIS) ) just unveiled an announcement. Circio Holding ASA has requested Atlas to subscribe and pay for an additional tranche ...